Common measurements for modified adeno-associated viruses (AAVs), a gene therapy delivery method, showed substantial ...

Roche has exercised its option to license a novel capsid from Dyno Therapeutics for use in a gene therapy program for an ...

According to the scientists of the National Research University "BelSU", the obtained results allow us to conclude that the ...

National Institute of Standards and Technology scientists looked at multiple techniques used to measure the modified viruses ...

Explore our new AAV Titer ELISA and AAV Antibody Assay Kits, designed for exceptional specificity, sensitivity, and accuracy ...

Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and accurate ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no ...

The results come from five patients enrolled in the biotech's ingoing phase 1/2 study of RGX-111 – which uses an adeno-associated viral vector (AAV9) to deliver a gene coding for an enzyme that ...

Matika Bio partners with Childs Cure to develop gene therapy vectors for children Matika Bio collaborates with Childs Cure to ...

Currently, the DMD treatment landscape includes Sarepta’s Elevidys (delandistrogene moxeparvovec), the first FDA-approved ...